Zinzino has taken the decision to publish its interim report for the third quarter of 2017 earlier than previously communicated. 
The interim report for the period of January-September 2017 will be published on 13th of November, contrary to earlier communications. It was initially scheduled for release on 20th of November. 
For more information:

Dag Bergheim Pettersen, CEO Zinzino, Tel. +47 93 22 57 00 www.zinzino.se 
Pictures for publication free of charge:
Marcus Tollbom, Tel. + 46 (0) 70-190 03 12 
Certified Adviser:
Erik Penser, Bank Aktiebolag 
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 16.30 on 8th of November, 2017


About Us

Zinzino AB (publ.) is a direct sales company which operates through the EU, Norway, Iceland and in North America. Zinzino markets and sells products in two product lines: Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee and tea. Zinzino owns Norwegian BioActive Foods AS and the research and production unit Faun Pharma AS. Zinzino has over 120 employees. The company has its registered office in Gothenburg, and offices in Helsinki, Riga, Oslo and in Florida, United States. Zinzino is a public limited company and its shares are listed on Nasdaq First North.


Documents & Links